
Secnid DS1 gm
Square Pharmaceuticals PLC.
Secnidazole is a nitroimidazole antimicrobial with antiprotozoal and antibacterial activity.
Secnidazole is a nitroimidazole antimicrobial with antiprotozoal and antibacterial activity. Its indications differ somewhat by regulatory approval, but Secnidazole is used for the following:
Secnidazole is particularly valued because its long half-life allows effective single-dose regimens in several of these infections, which can improve patient adherence compared with multi-day nitroimidazole courses.
Dosing of Secnidazole is indication-specific. Take Secnidazole exactly as prescribed by your physician; do not stop, extend, skip doses, or share this medicine with others without medical advice.
| Indication | Adult Dose | Pediatric Dose |
|---|---|---|
| Bacterial vaginosis | Single 2 g oral dose | Not established under 12 years; 2 g single dose in patients 12–17 years |
| Trichomoniasis | Single 2 g oral dose (treat sexual partner simultaneously) | Not established under 12 years; 2 g single dose in patients 12–17 years |
| Acute intestinal amoebiasis | Single 2 g oral dose | Approximately 30 mg/kg as a single dose (maximum per adult dose) |
| Asymptomatic (cyst-passer) amoebiasis | 2 g once daily for 3 days | Approximately 30 mg/kg once daily for 3 days |
| Hepatic amoebiasis | 1.5 g once daily for 5 days | Approximately 30 mg/kg once daily for 5 days |
| Giardiasis | Single 2 g oral dose | Approximately 30–50 mg/kg as a single dose |
Administration: Secnidazole tablets are taken orally, generally with food to minimize gastrointestinal upset. Where Secnidazole is supplied as oral granules, the entire contents of the packet should be sprinkled onto a spoonful of soft food such as applesauce, yogurt, or pudding and consumed within 30 minutes without chewing the granules; the granules should not be dissolved directly in liquid.
Hepatic impairment: Because Secnidazole undergoes hepatic metabolism, dose reduction or extended dosing intervals should be considered in patients with significant hepatic impairment, under physician supervision.
Most adverse effects of Secnidazole are mild and self-limiting.
Patients should seek medical attention if severe skin reactions, persistent neurological symptoms, or signs of blood dyscrasia (unusual bruising, bleeding, infection) occur while taking Secnidazole.
Secnidazole is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.